Cargando…
Essential role of insulin-like growth factor 2 in resistance to histone deacetylase inhibitors
Histone deacetylase inhibitors (HDIs) are promising anticancer therapies and have been clinically used for the treatment of hematological malignancy. However, their efficacy in solid tumors is marginal and drug resistance hampers their further clinical utility. To develop novel strategies for the HD...
Autores principales: | Lee, Su-Chan, Min, Hye-Young, Jung, Hyun Jin, Park, Kwan Hee, Hyun, Seung Yeob, Cho, Jaebeom, Woo, Jong Kyu, Kwon, So Jung, Lee, Hyo-Jong, Lee, Ho-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069101/ https://www.ncbi.nlm.nih.gov/pubmed/27086926 http://dx.doi.org/10.1038/onc.2016.92 |
Ejemplares similares
-
Histone Deacetylase 1 and Sirtuin 1 Expression in Psoriatic Skin: A Comparison between Guttate and Plaque Psoriasis
por: Hwang, Young-Ji, et al.
Publicado: (2020) -
Ninjurin1 drives lung tumor formation and progression by potentiating Wnt/β-Catenin signaling through Frizzled2-LRP6 assembly
por: Hyun, Seung Yeob, et al.
Publicado: (2022) -
Histone Deacetylase 3 and 4 Complex Stimulates the Transcriptional Activity of the Mineralocorticoid Receptor
por: Lee, Hae-Ahm, et al.
Publicado: (2015) -
New Aspects of Vascular Calcification: Histone Deacetylases and Beyond
por: Kwon, Duk-Hwa, et al.
Publicado: (2017) -
Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer
por: Min, Hye-Young, et al.
Publicado: (2015)